Molecular Nanofibers of Olsalazine Form Supramolecular Hydrogels for Reductive Release of an Anti-inflammatory Agent
摘要:
Conjugation of tripeptide derivatives with olsalazine, a clinically used anti-inflammatory prodrug, yields small molecules that self-assemble in water to form supramolecular hydrogels that undergo a gel-to-sol phase transition upon reduction, resulting in the controlled release of 5-aminosalicylic acid as the anti-inflammatory agent. This methodology will ultimately lead to new biomaterials for site-specific drug delivery.
[EN] USE OF N-SUBSTITUTED L-PHENYLALANINE ESTERS FOR THE TREATMENT OF ECZEMA<br/>[FR] UTILISATION D'ESTERS DE LA PHENYLALANINE N-SUBSTITUEE POUR LE TRAITEMENT DE L'ECZEMA
申请人:STIEFEL LABORATORIES, INC.
公开号:WO1996027373A1
公开(公告)日:1996-09-12
(EN) Non-polar hydrolysable N-substitued L-phenylalanine esters are applied to the skin to treat eczema. The preferred ester is N-acetyl-L-phenylalanine ethyl ester.(FR) On applique des esters de la phénylalanine N-substituée, qui sont non polaires et qui sont hydrolysables sur la peau, pour traiter l'eczéma. L'ester préféré est l'ester éthylique de la N-acétyl-L-phénylalanine.